Kinnevik Investment


Upgrading our NAV; Babylon goes the SPAC route

03/06/21 -"We updated our estimated DCF following the announcement of Babylon Health's definitive merger agreement with the SPAC Alkuri Global, through which the London-based digital healthcare company will ..."

Pages
63
Language
English
Published on
03/06/21
You may also be interested by these reports :
16/10/25
After a difficult Q2 25, Industrivärden posted improving Q3 25 results with a 4% increase in its NAV qoq to SEK 173bn or SEK 401 per share. This ...

16/10/25
Investor reported rather good results in Q3-25, with good NAV growth driven by all assets. The interesting takeaway from this release is that ...

16/10/25
Kinnevik reported good Q3 results, driven by the fundamentals as we like. The HoldCo is becoming increasingly conservative, with increasing maturity ...

16/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO